Clinical Trial Update: Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

A Phase 3 long-term extension trial of venlafaxine ER for major depressive disorder has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Venlafaxine ER (venlafaxine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-05-15